Trial Profile
Evaluation of Community-based Screening and Treatment for Malaria in the KEMRI/CDC Health and Demographic Surveillance System (HDSS) in Western Kenya
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Dec 2016
Price :
$35
*
At a glance
- Drugs Dihydroartemisinin/piperaquine (Primary)
- Indications Malaria
- Focus Therapeutic Use
- Acronyms MSaT
- 13 Dec 2016 New trial record